Study on XRCC1 Gene Variants and Breast Cancer Risk
Author Information
Author(s): Alpa V Patel, Eugenia E Calle, Alexandre L Pavluck, Heather Spencer Feigelson, Michael J Thun, Carmen Rodriguez
Primary Institution: American Cancer Society
Hypothesis
Does genetic variation in XRCC1 influence postmenopausal breast cancer risk?
Conclusion
Genetic variation in XRCC1, particularly the Arg194Trp polymorphism, may influence postmenopausal breast cancer risk, especially among smokers.
Supporting Evidence
- Trp194 carriers had a 38% lower incidence of breast cancer compared to non-carriers.
- The association was stronger among smokers, with an odds ratio of 2.76 for the Arg399Gln polymorphism.
- The study included 502 breast cancer cases matched with 502 controls.
Takeaway
This study found that some changes in a gene related to DNA repair might make women more or less likely to get breast cancer, especially if they smoke.
Methodology
The study used a case-control design with 502 breast cancer cases and 502 matched controls, analyzing XRCC1 polymorphisms through genotyping.
Potential Biases
Potential for selection bias was minimized by prospective data collection.
Limitations
Limited statistical power to examine interactions due to small sample size and low smoking prevalence.
Participant Demographics
Participants were predominantly white women aged 50 to 74 years.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI 0.40 to 0.95 for Trp194 carriers
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website